Cencora's FormularyDecisions Launches Payer Resource for Cell and Gene Therapy ProductsBusiness Wire • 02/08/24
Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of ProceedsBusiness Wire • 02/07/24
Cencora (COR) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/01/24
Unlocking Q1 Potential of Cencora (COR): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 01/26/24
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings ReleaseBusiness Wire • 01/04/24
Cencora: Continued Economic Value On The Table Across All Investment HorizonsSeeking Alpha • 01/04/24